06001442 · Active · incorporated 19 years, 8 months ago · Sandwich
Biotech Biotech & Life Sciences Drug Discovery Series B+
Akamis Bio develops oncolytic immunotherapies, particularly for colorectal cancer, aiming to advance cancer treatment.
See the complete cap table with every shareholder, founder tags, dilution across 56 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.